Status Asthmaticus Clinical Trial
Official title:
Using Pleth Variability to Triage Asthmatics in the Pediatric ED
Research has shown that pleth variability can be used to assess asthma severity in children with status asthmaticus. The investigators would like to use an FDA-cleared monitor (Masimo Radical 7) which measures Pleth Variability Index (PVI) to see if the degree of PVI can be used to help triage patients who present to the pediatric ED in status asthmaticus.
Patients with asthma have obstruction to exhalation resulting in hyperinflation of their
lungs. This hyperinflation results in a phenomenon known as pulsus paradoxus in which the
physiologic drop in blood pressure normally seen with inhalation is exaggerated. Studies
have shown that patients with more severe asthma exacerbations (i.e. more hyperinflation)
have a greater degree of pulsus paradoxus. Typically, pulsus paradoxus is measured using a
sphygmomanometer, however, researchers have demonstrated that it can also accurately be
measured using plethysmography, a term known as pleth variability index (PVI). Using this
concept, Arnold et al (2008, 2010) showed that a greater degree of pulsus paradoxus
correlates with asthma severity.
The investigators' study aims to simplify the association between PVI and asthma severity.
The investigators hypothesize the following:
1. Patients with a higher admission PVI will have a higher likelihood of being admitted to
the hospital.
2. Patients admitted to the Intensive Care Unit (PICU) will have a higher PVI than
patients admitted to a floor.
3. PVI can be accurately used to gauge response to bronchodilator/anti-inflammatory
therapy.
4. PVI is as effective as respiratory severity score in predicting asthma severity and in
gauging response to bronchodilator therapy.
To do this the investigators will recruit children who present to the pediatric ED in status
asthmaticus. They will be connected to a Masimo Radical 7 monitor upon admission to the ED
and then again 4 hours later. In addition the investigators will calculate respiratory
severity scores at those same time intervals. The investigators will then look at the
disposition of the patient upon leaving the ED: discharge to home, admission to an inpatient
floor or admission to the ICU.
;
Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02872597 -
Phase I, Placebo-Controlled, Blinded Pilot Study of Ipratropium in Children Admitted to the ICU With Status Asthmaticus
|
Phase 1 | |
Terminated |
NCT02966184 -
Comparison of Albuterol for Status Asthmaticus
|
Phase 4 | |
Enrolling by invitation |
NCT00750568 -
Intravenous Terbutaline in Severe Status Asthmaticus
|
N/A | |
Completed |
NCT00124995 -
Trial of Terbutaline for the Treatment of Status Asthmaticus in Children
|
Phase 4 | |
Recruiting |
NCT05819541 -
Treating Exacerbations of Asthma With Oral Montelukast in Children
|
Phase 2 | |
Completed |
NCT01524198 -
The Use of Inhaled Corticosteroids in the Treatment of Asthma is Children in the Emergency Room
|
Phase 2/Phase 3 | |
Terminated |
NCT02780479 -
Steroids in Children Hospitalized With Asthma
|
Phase 4 | |
Withdrawn |
NCT01403428 -
Non Invasive Positive Pressure Ventilation in Status Asthmaticus
|
Phase 2 | |
Terminated |
NCT00683449 -
Study Evaluating the Safety and Effects of MN-221 in Subjects Experiencing an Acute Exacerbation of Asthma
|
Phase 2 | |
Withdrawn |
NCT03219736 -
NiPPV in the Treatment of Acute Asthma Exacerbations
|
N/A | |
Completed |
NCT00722020 -
HFCWO in Hospitalized Asthmatic Children
|
N/A | |
Withdrawn |
NCT03338205 -
The Role of Ketamine as an Adjuvant Therapy for Children With Acute Status Asthmaticus
|
Phase 3 | |
Recruiting |
NCT01770899 -
Evaluation Montelukast in the Treatment of Status Asthmaticus
|
N/A | |
Withdrawn |
NCT01188473 -
Early Noninvasive Positive Pressure Ventilation in Children With Status Asthmaticus
|
Phase 1 | |
Withdrawn |
NCT04656587 -
BPAP in Pediatric Asthma Pilot Study
|
N/A | |
Completed |
NCT04929626 -
Different Doses of Nebulized Magnesium Sulphate in Status Asthmaticus
|
Phase 1 | |
Completed |
NCT00623688 -
Effectiveness and Cost Study Comparing Two Ways to Deliver Albuterol for the Treatment of Asthma in the Hospital
|
N/A | |
Recruiting |
NCT00494572 -
Montelukast With Status Asthmaticus, Ages 6-18
|
Phase 2/Phase 3 | |
Recruiting |
NCT00491790 -
Montelukast With Status Asthmaticus, Ages 2-5
|
Phase 2/Phase 3 | |
Completed |
NCT00279786 -
B2-Adrenergic Receptor Polymorphisms
|